PFC
MIRM icon

Phocas Financial Corp’s Mirum Pharmaceuticals MIRM Stock Holding History

Phocas Financial Corp’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35,561
Closed -$1.81M – 154
2025
Q2 		$1.81M Buy
35,561
+5
+0% +$223 0.26% 105
2025
Q1 		$1.6M Sell
35,556
-2,029
-5% -$95.6K 0.25% 109
2024
Q4 		$1.55M Sell
37,585
-304
-0.8% -$12.7K 0.21% 118
2024
Q3 		$1.48K Sell
37,889
-22,510
-37% -$898K 0.01% 135
2024
Q2 		$2.06K Sell
60,399
-1,137
-2% -$29.8K 0.01% 128
2024
Q1 		$1.55K Buy
+61,536
New +$1.69M 0.01% 135

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Phocas Financial Corp's MIRM Position: Q3 2025 in Review

Phocas Financial Corp sold out of Mirum Pharmaceuticals (MIRM) in Q3 2025, closing a stake of 35,561 shares — an estimated $1.81M sold.

Phocas Financial Corp first reported a position in MIRM in Q1 2024 and held it in 6 quarters. The position peaked at $1.81M in Q2 2025. 272 funds tracked by Wall St. Rank hold MIRM as of Q3 2025.

  • Phocas Financial Corp reported no remaining Mirum Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Phocas Financial Corp sold 35,561 Mirum Pharmaceuticals shares in Q3 2025, an estimated $1.81M.
  • Phocas Financial Corp first reported a position in Mirum Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • Phocas Financial Corp's Mirum Pharmaceuticals position peaked at $1.81M in Q2 2025.
  • 272 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2025.

Based on Phocas Financial Corp's 13F filing for Q3 2025, filed 12 Nov 2025.